Advancing a Preclinical Pipeline of ADCs Targeting Gastrointestinal Cancers
- Overviewing the landscape of ADC development in colorectal and other GI cancers
- Exploring discovery and preclinical development of SOT109 with potential best-inclass GI cancer-directed ADC targeting CDH17
- Exploiting innovative dualtargeting ADC approaches as novel therapeutic strategy for GI and other tumors